Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Scott C. Blair
Observed names:
S. Blair,
Scott Cameron Blair
Institution:
Columbus Community Clinical Oncology Program
Observed institutions:
Wayne State University,
Columbus Oncology and Hematology Associates,
Hematology Oncology Consultants,
Columbus Community Clinical Oncology Program,
University College London
OpenAlex ID:
A5045290402
Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients
1991
·
R. Chopra
, S. Blair
, et al.
·
Journal of Antimicrobial Chemotherapy
·
96
Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial
2001
·
C.H. Spiridonidis
, L.R. Laufman
, et al.
·
Annals of Oncology
·
43
PDF
Ifosfamide and Etoposide in the Treatment of Advanced Soft Tissue Sarcomas
1994
·
Scott C. Blair
, Mark M. Zalupski
, et al.
·
American Journal of Clinical Oncology
·
32
Phase III double‐blind, placebo‐controlled study of gabapentin for the prevention of delayed chemotherapy‐induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance)
2014
·
Debra L. Barton
, Gita Thanarajasingam
, et al.
·
Cancer
·
23
Does gabapentin prevent delayed chemotherapy-induced nausea and vomiting (N/V)? Results of a randomized placebo controlled trial, NCCTG N08C3 (Alliance).
2013
·
Debra L. Barton
, Jeff A. Sloan
, et al.
·
Journal of Clinical Oncology
·
2
Show more works
View as search
Works count:
5
Citation count:
196
H-index:
4
I10-index:
4
Year
Topic
Type